PT-141 10MG

Description

Introducing PT-141 10mg from Peptide Therapeutics Institute, a synthetic peptide studied extensively for its effects on sexual motivation, arousal, and neurobehavioral activation. Known as Bremelanotide, PT-141 works by interacting with melanocortin receptors in the central nervous system, particularly MC3R and MC4R, which play key roles in regulating libido and emotional drive. Unlike traditional compounds that act on the vascular system, PT-141 influences neural pathways tied to desire and reward. Research models have demonstrated that this peptide can enhance dopamine activity, stimulate hypothalamic regions, and promote behavioral patterns linked to sexual interest and interpersonal engagement. It is currently being explored for its potential in studies involving sexual dysfunction, mood, and motivation-related disorders. Advance your behavioral and neuroendocrine research with Peptide Therapeutics Institute’s PT-141 10mg.

Features

• Synthetic peptide studied for libido and arousal enhancement
• Targets central melanocortin receptors involved in desire and behavior
• Non-hormonal pathway distinct from PDE5 inhibitors or hormone therapy
• Investigated for applications in sexual dysfunction and emotional regulation
• May support motivation, reward sensitivity, and mood balance
• Applicable in both psychosexual and neurobehavioral research models

Why Choose Peptide Therapeutics Institute’s PT-141 10mg?

Peptide Therapeutics Institute’s PT-141 10mg offers researchers a highly pure, research-grade peptide optimized for studies in behavioral science and central nervous system function. With its unique action on neural melanocortin receptors, PT-141 is frequently utilized in models addressing hypoactive sexual desire, psychogenic dysfunction, and motivational imbalance. It is especially valuable for research into non-hormonal mechanisms of arousal and central modulation of emotional states. This peptide has demonstrated reliable effects in rodent and human studies, offering reproducible outcomes in both short-term and longitudinal protocols. Whether used in studies of mood, intimacy, or neurochemical signaling, Peptide Therapeutics Institute delivers consistent, high-quality PT-141 to support advanced investigative work.

Specs

Volume: 10 MG
Purity: Research Grade

Composition:

• Bremelanotide (PT-141)

Molecular Weight: Approximately 1025.2 Da

Stability: Stable under standard laboratory storage conditions